HCAHCA Healthcare, Inc.

NYSE hcahealthcare.com


$ 308.71 $ -0.60 (-0.19 %)    

Thursday, 02-May-2024 15:59:50 EDT
QQQ $ 429.07 $ 5.38 (1.28 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 4.68 (0.94 %)
TLT $ 88.87 $ 0.38 (0.43 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 308.84
$ 311.65
$ 0.00 x 0
$ 0.00 x 0
$ 307.40 - $ 311.65
$ 215.03 - $ 335.83
868,486
na
82.77B
$ 1.42
$ 15.13
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-16-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-17-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-01-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-18-2022 12-31-2021 10-K
11 11-01-2021 09-30-2021 10-Q
12 08-02-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-19-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 07-30-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-20-2020 12-31-2019 10-K
19 11-01-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-03-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-23-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 02-22-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 10-29-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-05-2015 03-31-2015 10-Q
38 02-26-2015 12-31-2014 10-K
39 11-04-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-buy-on-hca-healthcare-lowers-price-target-to-360

TD Cowen analyst Gary Taylor maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $371 to $360.

 barclays-maintains-overweight-on-hca-healthcare-raises-price-target-to-367

Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $356 to $...

 rbc-capital-maintains-outperform-on-hca-healthcare-raises-price-target-to-329

RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $322 ...

 oppenheimer-maintains-outperform-on-hca-healthcare-raises-price-target-to-345

Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target fro...

 tech-stocks-rebound-as-magnificent-7-roar-on-strong-earnings-energy-giants-tumble-whats-driving-markets-friday

Strong earnings reports from Alphabet Inc. (NASDAQ:GOOGL) and Microsoft Corp. (NASDAQ:MSFT) have restored positive sentiment in...

 why-is-hca-healthcare-stock-trading-lower-on-friday

HCA Healthcare's first-quarter results, surpassing revenue and EPS expectations. CEO Sam Hazen emphasizes sustained momentu...

 hca-healthcare-exec-says-co-continues-to-see-good-trends-on-contract-labor

-Conf. Call

 hca-healthcare-q1-2024-adj-eps-536-beats-501-estimate-sales-17339b-beat-16779b-estimate

HCA Healthcare (NYSE:HCA) reported quarterly earnings of $5.36 per share which beat the analyst consensus estimate of $5.01 by ...

 studies-led-by-harvard-pilgrim-health-care-institute-hca-healthcare-and-the-university-of-california-irvine-announce-two-clinical-trials-identified-a-better-way-to-target-appropriate-antibiotics-for-patients-hospitalized-with-pneumonia-or-urinary-tract-infection

Algorithm driven alerts help identify best antibiotic for patients with common infections in two 59-hospital trials, with impli...

 deutsche-bank-maintains-buy-on-hca-healthcare-raises-price-target-to-359

Deutsche Bank analyst Pito Chickering maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $330 t...

 cantor-fitzgerald-reiterates-overweight-on-hca-healthcare-maintains-335-price-target

Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:HCA) with a Overweight and maintains $335 price target.

 wells-fargo-maintains-equal-weight-on-hca-healthcare-raises-price-target-to-315

Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION